CSIMarket
 

Icecure Medical Ltd  (NASDAQ: ICCM)

Icecure Medical Ltd's

Competitiveness




 

ICCM Sales vs. its Competitors Q4 2025



Comparing the current results to its competitors, Icecure Medical Ltd reported Revenue increase in the 4 quarter 2025 by 0 % year on year.
The revenue growth was below Icecure Medical Ltd's competitors' average revenue growth of 6.29 %, achieved in the same quarter.

List of ICCM Competitors

With a net margin of 445.61 % Icecure Medical Ltd achieved higher profitability than its competitors.

More on ICCM Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Icecure Medical Ltd Net Income in the 4 quarter 2025 grew year on year by 0%, while most of its competitors have experienced a contraction in net income by -32.61 %.

<<  ICCM Stock Performance Comparisons


Icecure Medical Ltd's Comment on Competition and Industry Peers


The company operates in a competitive cancer cryoablation care market, facing significant competition from Boston Scientific Corporation, Siemens Healthineers, and Hygea Medical Technology Co. Ltd., which hold substantial market shares. The company's ability to introduce and market its products may be constrained by these competitors' dominant positions. The company depends heavily on its strategic relationship and distribution agreements with Terumo Corporation, whose effectiveness in product servicing and regulatory approvals in Japan is crucial to the company's sales and financial performance. Additionally, the company competes with various other firms involved in the research, development, manufacture, and marketing of non-invasive or minimally invasive tumor treatment technologies and medical devices, some of which possess greater financial and marketing resources.



*Market share is calculated based on total revenue.

  News about Icecure Medical Ltd Contracts

Revolutionary Breakthrough in Extra-Pelvis Endometriosis Treatment Unleashes Hope for Millions

March 4, 2024
IceCure Medical Ltd., an Israeli medical technology company...





Publicly Traded Peers of Icecure Medical Ltd




Atrion Corporation
Share Performance



-5.30%
One Year



Atrion Corporation
Profile

Atrion Corporation's business model focuses on developing and manufacturing medical devices and components for the healthcare industry.

More about Atrion Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 810.839 mill. $ 181.602 mill. $ 12.557 mill.


Utah Medical Products Inc
Share Performance



-3.13%
30 Days



Utah Medical Products Inc
Profile

Utah Medical Products Inc's business model revolves around the manufacturing and sale of medical devices and equipment.

More about Utah Medical Products Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 222.475 mill. $ 35.679 mill. $ 10.486 mill.


Vapotherm Inc
Share Performance



-27.67%
One Year



Vapotherm Inc
Profile

Vapotherm Inc operates under a business model that focuses on providing innovative respiratory support solutions to hospitals and healthcare facilities. They offer high-flow therapy systems and devices that deliver heated, humidified, and oxygenated air to patients with respiratory issues, aiming to improve patient outcomes and reduce the need for invasive interventions. Through strategic partnerships with hospitals and direct sales to healthcare providers, Vapotherm aims to both improve patient care and generate revenue from the sales of their products.

More about Vapotherm Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13.981 mill. $ 70.919 mill. $ -54.422 mill.


Vaso Corporation
Share Performance



+140.83%
One Year



Vaso Corporation
Profile

Vaso Corporation operates using a diversified business model, offering a range of products and services in the healthcare industry. Their model includes providing medical equipment, healthcare software solutions, and maintenance services to hospitals and healthcare facilities worldwide. Additionally, Vaso Corporation offers consulting services related to healthcare technology and workflow optimization.

More about Vaso Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 50.964 mill. $ 80.220 mill. $ 2.498 mill.


Zimmer Biomet Holdings Inc
Share Performance



-6.52%
Over The Past 5 Days



Zimmer Biomet Holdings Inc
Profile

Zimmer Biomet Holdings Inc operates as a global leader in musculoskeletal healthcare, focusing on the design, manufacture, and marketing of innovative medical devices for joint replacement, sports medicine, spine, and dental implants. Their business model emphasizes improving patient outcomes and advancing the field through advanced surgical products and solutions targeted at healthcare professionals worldwide.

More about Zimmer Biomet Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 17,828.216 mill. $ 8,508.800 mill. $ 807.100 mill.

19 more competitors available

Sign in to see all competitors

Sources: Icecure Medical Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Icecure Medical Ltd versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.